You are here

  • Home
  • Online First
  • Correspondence on “New EULAR/ACR 2019 SLE classification criteria: defining ominosity in SLE” by Whittall Garcia et al

Article info

Article menu

This article has a Reply. Please see:

Download PDFPDF

Correspondence
Correspondence on “New EULAR/ACR 2019 SLE classification criteria: defining ominosity in SLE” by Whittall Garcia et al
Free

Authors

  • Guillermo J Pons-Estel Departament of Rheumatology, Grupo Oroño-Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Santa Fe, Argentina PubMed articlesGoogle scholar articles
  • Manuel F. Ugarte-Gil Rheumatology, Hospital Guillermo Almenara Irigoyen. EsSalud, Lima, PeruUniversidad Científica del Sur, Lima, Peru PubMed articlesGoogle scholar articles
  • Guillermina B Harvey Escuela de Estadística, Facultad de Ciencias Económicas y Estadística, Universidad Nacional de Rosario, Rosario, Argentina PubMed articlesGoogle scholar articles
  • Bernardo A Pons-Estel Departament of Rheumatology, Grupo Oroño-Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Santa Fe, Argentina PubMed articlesGoogle scholar articles
  • Graciela S Alarcón Division of Clinical Immunology and Rheumatology, Department of Medicine, School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USADepartment of Medicine, School of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Guillermo J Pons-Estel, Departament of Rheumatology, Grupo Oroño-Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Santa Fe, Argentina; gponsestel{at}hotmail.com
View Full Text

Citation

Pons-Estel GJ, Ugarte-Gil MF, Harvey GB, et al
Correspondence on “New EULAR/ACR 2019 SLE classification criteria: defining ominosity in SLE” by Whittall Garcia et al
Annals of the Rheumatic Diseases Published Online First: 03 August 2021. doi: 10.1136/annrheumdis-2021-220994

Publication history

  • Received June 17, 2021
  • Accepted June 18, 2021
  • First published August 3, 2021.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.